BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15170136)

  • 1. High expression of integrin beta1 and p53 is a greater poor prognostic factor than clinical stage in small-cell lung cancer.
    Oshita F; Kameda Y; Hamanaka N; Saito H; Yamada K; Noda K; Mitsuda A
    Am J Clin Oncol; 2004 Jun; 27(3):215-9. PubMed ID: 15170136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of integrin beta1 is a poor prognostic factor in small-cell lung cancer.
    Oshita F; Kameda Y; Ikehara M; Tanaka G; Yamada K; Nomura I; Noda K; Shotsu A; Fujita A; Arai H; Ito H; Nakayama H; Mitsuda A
    Anticancer Res; 2002; 22(2B):1065-70. PubMed ID: 12168902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of survivin, cyclin D1, integrin beta1, and VEGF in patients with small adenocarcinoma of stage I lung cancer.
    Oshita F; Ito H; Ikehara M; Ohgane N; Hamanaka N; Nakayama H; Saito H; Yamada K; Noda K; Mitsuda A; Kameda Y
    Am J Clin Oncol; 2004 Aug; 27(4):425-8. PubMed ID: 15289739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
    Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
    Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallothionein expression in patients with small cell carcinoma of the lung: correlation with other molecular markers and clinical outcome.
    Joseph MG; Banerjee D; Kocha W; Feld R; Stitt LW; Cherian MG
    Cancer; 2001 Aug; 92(4):836-42. PubMed ID: 11550155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.
    Micke P; Basrai M; Faldum A; Bittinger F; Rönnstrand L; Blaukat A; Beeh KM; Oesch F; Fischer B; Buhl R; Hengstler JG
    Clin Cancer Res; 2003 Jan; 9(1):188-94. PubMed ID: 12538468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of integrin β1, E-cadherin, and rac1 expression in small cell lung cancer.
    Chang MH; Lee K; Lee KY; Kim YS; Kim YK; Kang JH
    APMIS; 2012 Jan; 120(1):28-38. PubMed ID: 22151306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-erbB-2 expression in small-cell lung cancer is associated with poor prognosis.
    Micke P; Hengstler JG; Ros R; Bittinger F; Metz T; Gebhard S; Beeh KM; Oesch F; Buhl R
    Int J Cancer; 2001 May; 92(4):474-9. PubMed ID: 11304679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of p53 oncoprotein expression with chemotherapy response in small cell lung carcinomas.
    Rodríguez-Salas N; Palacios J; Moreno G; de Castro J; González-Barón M; Gamallo C
    Lung Cancer; 2001 Oct; 34(1):67-74. PubMed ID: 11557115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.
    Dingemans AM; Witlox MA; Stallaert RA; van der Valk P; Postmus PE; Giaccone G
    Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
    Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
    Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma.
    Xu HJ; Quinlan DC; Davidson AG; Hu SX; Summers CL; Li J; Benedict WF
    J Natl Cancer Inst; 1994 May; 86(9):695-9. PubMed ID: 8158700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of mutant p53 protein in small-cell lung cancer: relationship to treatment outcome.
    Gemba K; Ueoka H; Kiura K; Tabata M; Harada M
    Lung Cancer; 2000 Jul; 29(1):23-31. PubMed ID: 10880844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of integrin β1 as a prognostic biomarker for human lung adenocarcinoma using 2D-LC-MS/MS combined with iTRAQ technology.
    Zhang PF; Zeng GQ; Yi LZ; Liu JP; Wan XX; Qu JQ; Li JH; Li C; Tang CE; Hu R; Ye X; Chen Y; Chen ZC; Xiao ZQ
    Oncol Rep; 2013 Jul; 30(1):341-9. PubMed ID: 23677397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2 expression as a predictor of chemosensitivities and survival in small cell lung cancer.
    Takayama K; Ogata K; Nakanishi Y; Yatsunami J; Kawasaki M; Hara N
    Cancer J Sci Am; 1996; 2(4):212-6. PubMed ID: 9166534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
    Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
    Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
    Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer.
    Paik KH; Park YH; Ryoo BY; Yang SH; Lee JC; Kim CH; Ki SS; Kim JM; Park MJ; Ahn HJ; Choi W; Chung JH
    J Korean Med Sci; 2006 Feb; 21(1):35-9. PubMed ID: 16479062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of serum p53 antibodies in patients with limited-stage small cell lung cancer.
    Zalcman G; Trédaniel J; Schlichtholz B; Urban T; Milleron B; Lubin R; Meignin V; Couderc LJ; Hirsch A; Soussi T
    Int J Cancer; 2000 Jan; 89(1):81-6. PubMed ID: 10719735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer.
    Cheng YL; Lee SC; Harn HJ; Chen CJ; Chang YC; Chen JC; Yu CP
    Eur J Cardiothorac Surg; 2003 Feb; 23(2):221-8. PubMed ID: 12559346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.